Thursday, Jan 15, 2026 · SEC filings

What the smart money revealed on Jan 15

Real insider buys15insiders · $8.56M
Real insider sales32insiders · $26.2M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

295 insider filings came in. We hid 59 planned (10b5-1) sellers and 168 people whose filings were routine, like grants and tax withholding.

trending_up

Micron Technology (MU) Director Teyin Liu bought $7.82M

23,200 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 13–14
$7.82M
trending_up

Surrozen (SRZN) Director Tim Kutzkey bought $357K

17,993 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 3 beat Traded Jan 13–14
$357K
trending_up

Cosmos Health (COSM) CEO Grigorios Siokas bought $222K

493,495 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 7 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 7 beat Traded Jan 14
$222K
trending_up

Greenwich LifeSciences (GLSI) CEO and CFO Snehal Patel bought $53.7K

1,800 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 9 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 9 beat Traded Jan 13
$53.7K
trending_down

Jabil (JBL) Executive Chairman Mark Mondello sold $5.52M

Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 1.13M shares.

Real sale Form 4 Traded Jan 13–15
$5.52M
trending_down

Olema Pharmaceuticals (OLMA) CH. Operating & Financial OFF. Shane Kovacs sold $2.98M

Not marked as a planned 10b5-1 sale. Sold 43% of the shares they held directly. Still holds 139,727 shares.

Real sale Form 4 Sold 43% of stake Traded Jan 13–15
$2.98M
trending_down

Salesforce (CRM) Director Neelie Kroes sold $929K

Not marked as a planned 10b5-1 sale. Sold 35% of the shares they held directly. Still holds 7,299 shares.

Real sale Form 4 Sold 35% of stake Traded Jan 14
$929K
Show 11 more real buys
Show 29 more real sales
AIR AAR · Chairman John Holmes · Traded Jan 13–14
$2.65M
SRRK Scholar Rock Holding · CEO David Hallal · Traded Jan 13
$2.45M
FIVE Five Below · CAO Eric Specter · Traded Jan 13
$1.71M
FIVE Five Below · COO Kenneth Bull · Traded Jan 13–15
$1.43M
COST Costco Wholesale · Executive Vice President James Klauer · Traded Jan 14
$1.41M
QBTS D-Wave Quantum · President & CEO Alan Baratz · Traded Jan 14
$982K
RH Rh · Director Mark Demilio · Traded Jan 13–14
$936K
SRRK Scholar Rock Holding · President of R&D Akshay Vaishnaw · Traded Jan 13
$873K
SRRK Scholar Rock Holding · CFO Vikas Sinha · Traded Jan 13
$715K
SRRK Scholar Rock Holding · COO Keith Woods · Traded Jan 13
$715K
INVX Innovex International · President of North America Mark Reddout · Traded Jan 14
$500K
CRDO Credo Technology Group Holding · Director Sylvia Acevedo · Traded Jan 13
$350K
PLAB Photronics · Director Kang Lee · Traded Jan 13
$344K
INVX Innovex International · CEO Adam Anderson · Traded Jan 14
$331K
QBTS D-Wave Quantum · CFO John Markovich · Traded Jan 14
$258K
JBL Jabil · Director Anousheh Ansari · Traded Jan 13–15
$246K
APLS Apellis Pharmaceuticals · CEO Cedric Francois · Traded Jan 13
$226K
APLS Apellis Pharmaceuticals · General Counsel David Watson · Traded Jan 13
$128K
ACRE Ares Commercial Real Estate · CEO Bryan Donohoe · Traded Jan 14
$107K
APLS Apellis Pharmaceuticals · CFO Timothy Sullivan · Traded Jan 13
$85.6K
APLS Apellis Pharmaceuticals · Chief Technical Officer Nur Nicholson · Traded Jan 13
$58.1K
APLS Apellis Pharmaceuticals · Chief Scientific Officer Pascal Deschatelets · Traded Jan 13
$50.5K
AEO American Eagle Outfitters · Director Cary McMillan · Traded Jan 14
$49.7K
APLS Apellis Pharmaceuticals · Chief Business & Strat Officer Mark DeLong · Traded Jan 13
$39.5K
ACRE Ares Commercial Real Estate · Gen. Counsel VP and Secretary Anton Feingold · Traded Jan 14
$37.5K
ACRE Ares Commercial Real Estate · CFO and Treasurer Jeffrey Gonzales · Traded Jan 14
$30.7K
APLS Apellis Pharmaceuticals · VP/Chief Accounting Officer James Chopas · Traded Jan 13
$19.4K
RDNW RideNow Group · Executive Vice President Cameron Tkach · Traded Jan 2–Apr 1
$10.4K
CBDS Dogecoin Cash · CEO David Tobias · Traded Jan 14–15
$4.13K

13F season

Holdings as of Dec 31, 2025 are due Feb 17

320 funds have filed so far. 81 filed for the quarter before.

Biggest real insider buys this week

Open-market buys by officers and directors, filed in the 7 days up to Jan 15.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist